FindTrial
Sign In

A clinical comparative study of manual puncture and template guided puncture of gold marker implantation in cyberknife treatment for lung tumor.

Stereotactic radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16009915
Enrollment
Unknown
Registered
2016-11-18
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung tumor

Interventions

1:puncture with hand-free
2:template-guide puncture

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Pulmonary primary or metastatic tumor patients; 2. Suitable for local stereotactic radiotherapy; 3. need to implant the gold implantation for CyberKnife treatment.

Exclusion criteria

Exclusion criteria: 1. Severe cardiac and pulmonary dysfunction 2. Mental patients 3. Systemic infection in acute phase 4. >3 degrees of bone marrow suppression.

Design outcomes

Secondary

MeasureTime frame
Side-effect;—

Primary

MeasureTime frame
implantation location;—

Countries

China

Contacts

Public ContactHongqing Zhuang

Tianjin Medical University Cancer Institute and Hospital

yiduzhengmu@163.com+86 13752272283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026